Autocrine inhibitory influences of α-melanocyte-stimulating hormone in malignant pleural mesothelioma

Journal of Leukocyte Biology

Volumn 75, Issue 2, 2004, Pages 253-259

  Catania, Anna ^a   Colombo, Gualtiero ^a   Carlin, Andrea ^a   Garofalo, Letizia ^a   Gatti, Stefano ^a   Buffa, Roberto ^b   Carboni, Nadia ^a   Rosso, Lorenzo ^a   Santambrogio, Luigi ^a   Cantalamessa, Luigi ^a   Lipton, James M ^c  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

^c Zengen Inc   (United States)

Author keywords

Growth factors; Malignant mesothelioma; Melanocortin receptors (MCR); Proopiomelanocortin (POMC)

Indexed keywords

ALPHA INTERMEDIN; CYTOKINE; GROWTH FACTOR; INTERLEUKIN 6; INTERLEUKIN 8; MELANOCORTIN 1 RECEPTOR; MESSENGER RNA; PEPTIDE; PROOPIOMELANOCORTIN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; AUTOCRINE EFFECT; CANCER CELL CULTURE; CANCER GROWTH; CELL PROLIFERATION; CELL TYPE; CONTROLLED STUDY; GROWTH REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MESOTHELIOMA; MESOTHELIUM CELL; PLEURA CAVITY; PLEURA EFFUSION; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUPERNATANT;

ALPHA-MSH; AUTOCRINE COMMUNICATION; CELL DIVISION; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; IMMUNOHISTOCHEMISTRY; MESOTHELIOMA; PEPTIDE FRAGMENTS; PLEURAL NEOPLASMS; PRO-OPIOMELANOCORTIN; RECEPTOR, MELANOCORTIN, TYPE 1; RNA, NEOPLASM; TUMOR CELLS, CULTURED;

EID: 10744228408     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0603264     Document Type: Article

References (54)

1. Carbone, M., Kratzke, R. A., Testa, J. R. (2002) The pathogenesis of mesothelioma. Semin. Oncol. 29, 2-17.
2. Gerwin, B. I., Lechner, J. F., Reddel, R. R., Roberts, A. B., Robbins, K. C., Gabrielson, E. W., Harris, C. C. (1987) Comparison of production of transforming growth factor-β and platelet-derived growth factor by normal human mesothelial cells and mesothelioma cell lines. Cancer Res. 47, 6180-6184.
3. Nowak, A. K., Lake, R. A., Kindler, H. L., Robinson, B. W. (2002) New approaches for mesothelioma: biologics, vaccines, gene therapy, and other novel agents. Semin. Oncol. 29, 82-96.
4. Demetri, G. D., Zenzie, B. W., Rheinwald, J. G., Griffin, J. D. (1989) Expression of colony-stimulating factor genes by normal human mesothelial cells and human malignant mesothelioma cells lines in vitro. Blood 74, 940-946.
5. Galffy, G., Mohammed, K. A., Dowling, P. A., Nasreen, N., Ward, M. J., Antony, V. B. (1999) Interleukin 8: an autocrine growth factor for malignant mesothelioma. Cancer Res. 59, 367-371.
6. Langerak, A. W., De Laat, P. A., Van Der Linden-Van Beurden, C. A., Delahaye, M., Van Der Kwast, T. H., Hoogsteden, H. C., Benner, R., Versnel, M. A. (1996) Expression of platelet-derived growth factor (PDGF) and PDGF receptors in human malignant mesothelioma in vitro and in vivo. J. Pathol. 178, 151-160.
7. Janne, P. A., Taffaro, M. L., Salgia, R., Johnson, B. E. (2002) Inhibition of epidermal growth factor receptor signaling in malignant pleural mesothelioma. Cancer Res. 62, 5242-5247.
8. Eberle, A. (1988) The Melanotropins. Basel, Switzerland, Karger.
9. Catania, A., Lipton, J. M. (1993) α-Melanocyte stimulating hormone in the modulation of host reactions. Endocr. Rev. 14, 564-576.
10. Catania, A., Cutuli, M., Garofalo, L., Carlin, A., Airaghi, L., Barcellini, W., Lipton, J. M. (2000) The neuropeptide α-MSH in host defense. Ann. N. Y. Acad. Sci. 917, 227-231.
11. Chhajlani, V., Wikberg, J. E. (1992) Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA. FEBS Lett. 309, 417-420.
12. Mountjoy, K. G., Robbins, L. S., Mortrud, M. T., Cone, R. D. (1992) The cloning of a family of genes that encode the melanocortin receptors. Science 257, 1248-1251.
13. Cone, R. D., Lu, D., Koppula, S., Vage, D. I., Klungland, H., Boston, B., Chen, W., Orth, D. N., Pouton, C., Kesterson, R. A. (1996) The melanocortin receptors: agonists, antagonists, and the hormonal control of pigmentation. Recent Prog. Horm. Res. 51, 287-317.
14. Gantz, I., Miwa, H., Konda, Y., Shimoto, Y., Tashiro, T., Watson, S. J., DelValle, J., Yamada, T. (1993) Molecular cloning, expression, and gene localization of a fourth melanocortin receptor. J. Biol. Chem. 268, 15174-15179.
15. Gantz, I., Shimoto, Y., Konda, Y., Miwa, H., Dickinson, C. J., Yamada, T. (1994) Molecular cloning, expression, and characterization of a fifth melanocortin receptor. Biochem. Biophys. Res. Commun. 200, 1214-1220.
16. Gantz, I., Konda, Y., Tashiro, T., Shimoto, Y., Miwa, H., Munzert, G., Watson, S. J., DelValle, J., Yamada, T. (1993) Molecular cloning of a novel melanocortin receptor. J. Biol. Chem. 268, 8246-8250.
17. Manna, S. K., Aggarwal, B. B. (1998) α-Melanocyte-stimulating hormone inhibits the nuclear transcription factor NF-κB activation induced by various inflammatory agents. J. Immunol. 161, 2873-2880.
18. Ichiyama, T., Zhao, H., Catania, A., Furukawa, S., Lipton, J. M. (1999) α-Melanocyte-stimulating hormone inhibits NF-κB activation and IκBα degradation in human glioma cells and in experimental brain inflammation. Exp. Neurol. 157, 359-365.
19. Yamamoto, Y., Gaynor, R. B. (2001) Role of the NF-κB pathway in the pathogenesis of human disease states. Curr. Mol. Med. 1, 287-296.
20. Lipton, J. M., Catania, A. (1997) Anti-inflammatory actions of the neuroimmunomodulator α-MSH. Immunol. Today 18, 140-145.
21. Chiao, H., Foster, S., Thomas, R., Lipton, J., Star, R. A. (1996) α-Melanocyte-stimulating hormone reduces endotoxin-induced liver inflammation. J. Clin. Invest. 97, 2038-2044.
22. Brzoska, T., Kalden, D. H., Scholzen, T., Luger, T. A. (1999) Molecular basis of the α-MSH/IL-1 antagonism. Ann. N. Y. Acad. Sci. 885, 230-238.
23. Gatti, S., Colombo, G., Buffa, R., Turcatti, F., Garofalo, L., Carboni, N., Ferla, L., Fassati, L. R., Lipton, J. M., Catania, A. (2002) α-Melanocyte stimulating hormone protects the allograft in experimental heart transplantation. Transplantation 74, 1678-1684.
24. Scholzen, T. E., Sunderkotter, C., Kalden, D. H., Brzoska, T., Fastrich, M., Fisbeck, T., Armstrong, C. A., Ansel, J. C., Luger, T. A. (2003) α-Melanocyte stimulating hormone prevents lipopolysaccharide-induced vasculitis by down-regulating endothelial cell adhesion molecule expression. Endocrinology 144, 360-370.
25. Catania, A., Airaghi, L., Colombo, G., Lipton, J. M. (2000) α-Melanocyte-stimulating hormone in normal human physiology and disease states. Trends Endocrinol. Metab. 11, 304-308.
26. Wikberg, J. E., Muceniece, R., Mandrika, I., Prusis, P., Lindblom, J., Post, C., Skottner, A. (2000) New aspects on the melanocortins and their receptors. Pharmacol. Res. 42, 393-420.
27. Getting, S. J. (2002) Melanocortin peptides and their receptors: new targets for anti-inflammatory therapy. Trends Pharmacol. Sci. 23, 447-449.
28. Chomczynski, P., Sacchi, N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
29. Alley, M. C., Scudiero, D. A., Monks, A., Hursey, M. L., Czerwinski, M. J., Fine, D. L., Abbott, B. J., Mayo, J. G., Shoemaker, B. H., Boyd, M. R. (1988) Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res. 48, 589-601.
30. Bohm, M., Metze, D., Schulte, U., Becher, E., Luger, T. A., Brzoska, T. (1999) Detection of melanocortin-1 receptor antigenicity on human skin cells in culture and in situ. Exp. Dermatol. 8, 453-461.
31. Hartmeyer, M., Scholzen, T., Becher, E., Bhardwaj, R. S., Schwarz, T., Luger, T. A. (1997) Human dermal microvascular endothelial cells express the melanocortin receptor type 1 and produce increased levels of IL-8 upon stimulation with α-melanocyte-stimulating hormone. J. Immunol. 159, 1930-1937.
32. Taherzadeh, S., Sharma, S., Chhajlani, V., Gantz, I., Rajora, N., Demitri, M. T., Kelly, L., Zhao, H., Ichiyama, T., Catania, A., Lipton, J. M. (1999) α-MSH and its receptors in regulation of tumor necrosis factor-α production by human monocyte/macrophages. Am. J. Physiol. 276, R1289-R1294.
33. Masood, R., Kundra, A., Zhu, S., Xia, G., Scalia, P., Smith, D. L., Gill, P. S. (2003) Malignant mesothelioma growth inhibition by agents that target the VEGF and VEGF-C autocrine loops. Int. J. Cancer 104, 603-610.
34. Liu, Z., Klominek, J. (2003) Regulation of matrix metalloprotease activity in malignant mesothelioma cell lines by growth factors. Thorax 58, 198-203.
35. Favoni, R. E., de Cupis, A. (2000) The role of polypeptide growth factors in human carcinomas: new targets for a novel pharmacological approach. Pharmacol. Rev. 52, 179-206.
36. Liddle, G. W., Givens, J. R., Nicholson, W. E., Island, D. P. (1965) The ectopic ACTH syndrome. Cancer Res. 25, 1057-1061.
37. Vieau, D., Seidah, N. G., Mbikay, M., Chretien, M., Bertagna, X. (1994) Expression of the prohormone convertase PC2 correlates with the presence of corticotropin-like intermediate lobe peptide in human adrenocorticotropin-secreting tumors. J. Clin. Endocrinol. Metab. 79, 1503-1506.
38. Blalock, J. E. (1999) Proopiomelanocortin and the immune-neuroendocrine connection. Ann. N. Y. Acad. Sci. 885, 161-172.
39. Chakraborty, A. K., Funasaka, Y., Slominski, A., Ermak, G., Hwang, J., Pawelek, J. M., Ichihashi, M. (1996) Production and release of proopiomelanocortin (POMC) derived peptides by human melanocytes and keratinocytes in culture: regulation by ultraviolet B. Biochim. Biophys. Acta 1313, 130-138.
40. Star, R. A., Rajora, N., Huang, J., Stock, R. C., Catania, A., Lipton, J. M. (1995) Evidence of autocrine modulation of macrophage nitric oxide synthase by α-melanocyte-stimulating hormone. Proc. Natl. Acad. Sci. USA 92, 8016-8020.
41. Slominski, A., Wortsman, J. (2000) Neuroendocrinology of the skin. Endocr. Rev. 21, 457-487
42. Slominski, A., Wortsman, J., Luger, T., Paus, R., Solomon, S. (2000) Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol. Rev. 80, 979-1020.
43. Chhajlani, V., Muceniece, R., Wikberg, J. E. (1993) Molecular cloning of a novel human melanocortin receptor. Biochem. Biophys. Res. Commun. 195, 866-873.
44. Abdel-Malek, Z. A. (2001) Melanocortin receptors: their functions and regulation by physiological agonists and antagonists. Cell. Mol. Life Sci. 58, 434-441.
45. Bhardwaj, R., Becher, E., Mahnke, K., Hartmeyer, M., Schwarz, T., Scholzen, T., Luger, T. A. (1997) Evidence for the differential expression of the functional α-melanocyte-stimulating hormone receptor MC-1 on human monocytes. J. Immunol. 158, 3378-3384.
46. Catania, A., Rajora, N., Capsoni, F., Minonzio, F., Star, R. A., Lipton, J. M. (1996) The neuropeptide α-MSH has specific receptors on neutrophils and reduces chemotaxis in vitro. Peptides 17, 675-679.
47. Delgado, R., Carlin, A., Airaghi, L., Demitri, M. T., Meda, L., Galimberti, D., Baron, P., Lipton, J. M., Catania, A. (1998) Melanocortin peptides inhibit production of proinflammatory cytokines and nitric oxide by activated microglia. J. Leukoc. Biol. 63, 740-745.
48. Wong, K. Y., Rajora, N., Boccoli, G., Catania, A., Lipton, J. M. (1997) A potential mechanism of local anti-inflammatory action of α -melanocyte-stimulating hormone within the brain: modulation of tumor necrosis factor-α production by human astrocytic cells. Neuroimmunomodulation 4, 37-41.
49. Marzo, A. L., Fitzpatrick, D. R., Robinson, B. W., Scott, B. (1997) Antisense oligonucleotides specific for transforming growth factor β2 inhibit the growth of malignant mesothelioma both in vitro and in vivo. Cancer Res. 57, 3200-3207.
50. Galffy, G., Mohammed, K. A., Nasreen, N., Ward, M. J., Antony, V. B. (1999) Inhibition of interleukin-8 reduces human malignant pleural mesothelioma propagation in nude mouse model. Oncol. Res. 11, 187-194.
51. Antony, V. B., Hott, J. W., Godbey, S. W., Holm, K. (1996) Angiogenesis in mesotheliomas. Role of mesothelial cell derived IL-8. Chest 109, 21S-22S.
52. Nakano, T., Chahinian, A. P., Shinjo, M., Tonomura, A., Miyake, M., Togawa, N., Ninomiya, K., Higashino, K. (1998) Interleukin 6 and its relationship to clinical parameters in patients with malignant pleural mesothelioma. Br. J. Cancer 77, 907-912.
53. Monti, G., Jaurand, M. C., Monnet, I., Chretien, P., Saint-Etienne, L., Zeng, L., Portier, A., Devillier, P., Galanaud, P., Bignon, J., et al. (1994) Intrapleural production of interleukin 6 during mesothelioma and its modulation by γ-interferon treatment. Cancer Res. 54, 4419-4423.
54. Wikberg, J. E. (1999) Melanocortin receptors: perspectives for novel drugs. Eur. J. Pharmacol. 375, 295-310.